We are live on
!
Find out more
DIM
DLK Investment Management Portfolio holdings
AUM
$235M
1-Year Est. Return
12.41%
This Fund
S&P 500
This Quarter
Est. Return
-0.37%
1 Year Est. Return
+12.41%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$239M
AUM Growth
-$366K
(-0.15%)
Cap. Flow
+$3.92M
Cap. Flow
% of AUM
1.64%
Top 10 Holdings %
Top 10 Hldgs %
40.51%
Holding
94
New
5
Increased
34
Reduced
19
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Constellation Brands
STZ
|
+$5.7M |
| 2 |
Kenvue
KVUE
|
+$3.79M |
| 3 |
Becton Dickinson
BDX
|
+$579K |
| 4 |
Nike
NKE
|
+$528K |
| 5 |
Adobe
ADBE
|
+$509K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$4.35M |
| 2 |
JPMorgan Chase
JPM
|
+$1.96M |
| 3 |
RTX Corp
RTX
|
+$834K |
| 4 |
McCormick & Company Non-Voting
MKC
|
+$780K |
| 5 |
Walmart Inc
WMT
|
+$736K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.32% |
| 2 | Consumer Staples | 15.31% |
| 3 | Healthcare | 14.89% |
| 4 | Industrials | 14.42% |
| 5 | Financials | 13.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Heron Therapeutics
HRTX
$61.3M
| $38.3K | 0.02% |
17,390
| – | – |
|
77
ADC Therapeutics
ADCT
$150M
| $37.8K | 0.02% |
26,805
+1,000
| +4% | +$1.7K |
|
78
Cipher Digital
CIFR
$7.14B
| $37.5K | 0.02% |
16,300
| – | – |
|
79
Editas Medicine
EDIT
$453M
| $35.6K | 0.01% |
30,719
+5,000
| +19% | +$7.36K |
|
80
Arena Group
AREN
$76.2M
| $27.7K | 0.01% |
16,000
| – | – |
|
81
Black Diamond Therapeutics
BDTX
$120M
| $24.8K | 0.01% |
16,000
| – | – |
|
82
Quantum-Si Incorporated
QSI
$179M
| $22.8K | 0.01% |
19,000
| – | – |
|
83
Spero Therapeutics
SPRO
$71.2M
| $21.5K | 0.01% |
29,825
+870
| +3% | +$734 |
|
84
Passage Bio
PASG
$14.5M
| $18.7K | 0.01% |
2,650
| – | – |
|
85
Alector
ALEC
$233M
| $14.1K | 0.01% |
11,500
+1,000
| +10% | +$1.63K |
|
|
KEEL
86
Keel Infrastructure Corp
KEEL
$1.99B
| $10.6K | ﹤0.01% |
13,500
| – | – |
|
87
Revolution Medicines Inc Warrant
RVMDW
$128M
| $2.93K | ﹤0.01% |
77,000
| – | – |
|
88
Bionano Genomics
BNGO
$13.7M
| – | – |
-239
| Closed | -$4.14K |
|
|
DFS
89
DELISTED
Discover Financial Services
DFS
| – | – |
-2,539
| Closed | -$440K |
|
90
Goldman Sachs
GS
$301B
| – | – |
-393
| Closed | -$225K |
|
91
Hartford Financial Services
HIG
$38.1B
| – | – |
-2,155
| Closed | -$236K |
|
92
Twilio
TWLO
$39.3B
| – | – |
-2,350
| Closed | -$254K |
|
|
93
UnitedHealth
UNH
$365B
| – | – |
-8,607
| Closed | -$4.35M |
|
|
ZUO
94
DELISTED
Zuora, Inc.
ZUO
| – | – |
-11,800
| Closed | -$117K |
|
Similar funds
CF
JRPCML
MC
BWM
SP
AL3A
TCM
PVM
DLK Investment Management's Q1 2025 Portfolio in Review
As of Q1 2025, DLK Investment Management held 94 positions worth $239M, down 0.15% from $239M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
DLK Investment Management's Q1 2025 filing shows 5 new, 34 increased, 19 reduced and 7 closed positions. Its largest new stake was Constellation Brands: 31,379 shares worth $5.76M. The largest sale was UnitedHealth, an estimated $4.35M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Consumer Staples and Healthcare.
- DLK Investment Management's largest Q1 2025 buy was Constellation Brands: 31,379 shares worth $5.76M.
- DLK Investment Management added most to Becton Dickinson in Q1 2025, an estimated $579K increase.
- DLK Investment Management's biggest Q1 2025 reduction was JPMorgan Chase, cutting an estimated $1.96M.
- DLK Investment Management fully exited UnitedHealth in Q1 2025, selling an estimated $4.35M.
- DLK Investment Management's ten largest holdings make up 41% of its $239M portfolio in Q1 2025.
- DLK Investment Management opened 5 new positions and closed 7 in Q1 2025.
- DLK Investment Management's portfolio value fell 0.15% quarter-over-quarter to $239M.
Based on DLK Investment Management's 13F filing for Q1 2025, filed 23 Apr 2025.